Speaker Profile

Ph.D., CEO & Co-founder, SOPHiA GENETICS
Biography

Dr. Jurgi Camblong is a visionary entrepreneur who is pioneering the Data-Driven Medicine movement around the world. He is a Molecular Biologist (published in Cell, Science & Nature), has a PhD in Life Sciences from the University of Geneva, and an EMBA in Management of Technology from EPFL/HEC Lausanne. In 2011, he founded SOPHiA GENETICS with Dr. Pierre Hutter and Prof. Lars Steinmetz, and has since successfully been leading the development of the company, listed by the MIT Technology Review amongst the 50 smartest companies in 2017. Dr. Camblong is a member of the Advisory Council on Digital Transformation to the Swiss Federal Government, and was personally recognized by EY as Emergent Entrepreneur of the Year in 2017.

Session Abstract – PMWC 2018 Silicon Valley

Session Synopsis: Interpreting human DNA and predicting the molecular effects of genetic variation will aid in the understanding of human disease and is expected to increasingly provide personalized insights on health risks and recommended disease treatment. The rapid commercialization of AI/machine learning and big data is well positioned to over time change disease diagnosis and management.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.